InvestorRelations

Please contact us for any investor information using the form below.

CurrentNews

EmpowerPharm Patent- PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF CANNABINOIDS was published today.

EmpowerPharm® a clinical stage pharmaceutical company specializing in cannabinoid-based drug development of prescription products. These products target therapeutic indications where ...
Read More →

EmpowerPharm Inc. is pleased to report that the final patient has successfully completed treatment and played an active role in the Phase II clinical trial on evaluating the potential of Cannabidiol in managing Social Anxiety Disorder. 

EmpowerPharm Inc., a clinical-stage pharmaceutical company dedicated to research and clinical advancement, disclosed today that the last participant concluded the treatment and active involvement
Read More →

EmpowerPharm and Stella’s Place host Mental Health Forum

This was a virtual panel discussion between leading clinical experts on the state of anxiety in Canada discussing existing and ...
Read More →

Subscribe to get the latest news.